Giant Mitochondria in Chloroplast-Deprived Euglena gracilis Late after N-Succinimidylofloxacin Treatment

Folia Microbiologica

Volumn 43, Issue 6, 1998, Pages 661-666

  Polonyi J ^a   Ebringer, L ^a   Dobias, J ^a   Krajcovic J ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EUGLENA GRACILIS;

EID: 0032263372     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02816386     Document Type: Article

References (33)

1. BLUM J.J., SOMMER J.R., KAHN V.: Some biochemical, cytological, and morphogenetic comparison between Astasia longa and bleached Euglena gracilis. J.Protozool. 12, 202-209 (1965).
2. BREDBERG A., BRANT M., RIESBERG K., AZON Y., FORSGREN A.: 4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction. Mutat.Res. 211, 171-180 (1989).
3. BURKHARDT J.E., HILL M.A., TUREK J.J., CARLTON W.W.: Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet.Pathol. 29, 230-238 (1992).
4. CASTORA F.J., VISSERING F.F., SIMPSON M.V.: The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria. Biochim.Biophys.Acta 740, 417-427 (1983).
5. CRAMER M., MYERS J.: Growth and photosynthetic characteristic of Euglena gracilis. Arch.Microbiol. 17, 384-402 (1952).
6. DOBIAS J., UHER M., KOREŇOVÁ A., BRTKO J., BELICOVÁ A., FOLTÍNOVÁ P., EBRINGER L.: N-Succinimidyl ester of ofloxacin - a novel prodrug. Pharmazie 50, H.8, 563 (1995).
7. EBRINGER L.: Effects of drugs on chloroplasts, pp. 271-354 in F.E. Hahn (Ed.): Progress in Molecular and Subcellular Biology, Vol. 6. Springer Verlag, Berlin-Heidelberg-New York 1978.
8. EBRINGER L.: Interaction of drugs with extranuclear genetic elements and its consequences. Teratogen.Carcinogen.Mutagen. 10, 477-501 (1990).
9. EBRINGER L., KRAJČOVIČ J.: Are chloroplasts and mitochondria the remnants of prokaryotic endosymbionts? Folia Microbiol. 31, 228-254 (1986).
10. EBRINGER L., KRAJČOVIČ J.: Prokaryotic character of chloroplasts and mitochondria - the present state of knowledge. Folia Microbiol. 32, 244-280 (1987).
11. EBRINGER L., KRAJČOVIČ J., POLÓNYI J., LAHITOVÁ N., DOUPOVCOVÁ M., DOBIAS J.: Tetracycline reduces fluoroquinolones-induced bleaching of Euglena gracilis. Mutat.Res. 340, 141-149 (1996).
12. EBRINGER L., POLÓNYI J., KRAJČOVIČ J.: Influence of ofloxacin on chloroplasts and mitochondria in Euglena gracilis. Arzneim.-Forsch. 43 (II), 777-781 (1993).
13. EBRINGER L., POLÓNYI J., KRAJČOVIČ J., DOBIAS J.: Influence of tetracyclines or cetylpyridinium bromide on activity of fluoroquinolones in Euglena gracilis. Arzneim.-Forsch. 47 (I), 683-687 (1997).
14. GHADIALLY F.N.: Ultrastructural Pathology of the Cell and Matrix. Butherworth, London-Boston-Toronto 1982.
15. GLAUMANN B., TRUMP B.F.: Studies on the pathogenesis of ischemic cell injury. III. Morphological changes of the proximal pars recta tubules (P3) of the rat kidney made ischemic in vivo. Virchows Arch.B.Cell Path. 19, 303-323 (1975).
16. HAYEM G., PETIT P.X., LEVACHER M., GAUDIN C., KAHN M.-F., POCIDALO J.-J.: Cytofluorometric chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob.Agents Chemother. 38, 243-247 (1994).
17. HOOPER D.C., WOLFSON J.S. (Eds): Quinolone Antibacterial Agents. Second edition, American Society for Microbiology, Washington D.C. 1993a.
18. HOOPER D.C., WOLFSON J.S.: Mechanisms of quinolone action and bacterial killing, pp. 53-75 in D.C. Hooper and J.S. Wolfson (Eds): Quinolone Antibacterial Agents. Second edition, American Society for Microbiology, Washington D.C. 1993b.
19. KRAJČOVIČ J., EBRINGER L., POLÓNYI J.: Quinolones and coumarins eliminate chloroplasts from Euglena gracilis. Antimicrob. Agents Chemother. 33, 1883-1889 (1989).
20. LEVIN C.S., MORRISSEY I., SMITH J.T.: Role of oxygen in the bactericidal action of the 4-quinolones. Reviews of Infect.Diseases 11, Suppl. 5, 16-17 (1989).
21. MATSUHASHI T., LIU X., KARBOWSKI M., WOZNIAK M., ANTOSIEWICZ J., WAKABAYASHI T.: Role of free radicals in the mechanism of the hydrazine-induced formation of megamitochondria. Free Radical Biol.Med. 23, 285-293 (1997).
22. MATSUMOTO T., TAKAHASHI K., NAGAFUJI T., KUBO S., KUMUZAWA J.: Effect of inhibitors of protein kinase C on enhanced superoxide production of human leucocytes by ofloxacin and fleroxacin. Drugs 49, Suppl. 2, 286-288 (1995).
23. MRÁZ P., KAPELLER K., POLÓNYI J.: Standardization of glutaraldehyde for use in electron microscopy. Folia Morph. 29, 286-291 (1981).
24. MRÁZ P., POLÓNYI J.: Methods of Electron Microscopy of Animal Tissues (in Slovak). Veda, Bratislava 1988.
25. OBERNAUEROVÁ M., ŠUBÍK J.: Energy-dependent mitochondrial mutagenicity of antibacterial ofloxacin and its recombinogenic activity in yeast. Curr.Genet. 26, 281-284 (1994).
26. OSHEROFF N., ZECHIEDRICH E.L., GALE K.C.: Catalytic function of DNA topoisomerase II. Bio Essays 13, 269-275 (1991).
27. PHILLIPS I.: Bacterial mutagenicity and the 4-quinolones. J.Antimicrob.Chemother. 20, 771-773 (1987).
28. POLÓNYI J., EBRINGER L., KRAJČOVIČ J., KAPELLER K.: Ultrastructure of green and AF-2 nitrofuran-bleached mutants of Euglena gracilis. I. Volume of chloroplasts, mitochondria and paramylon granules. Biológia (Bratislava) 42, 217-229 (1987).
29. POLÓNYI J., EBRINGER L., KRAJČOVIČ J., KAPELLER K.: Injured mitochondria in cells of Euglena gracilis after DNA gyrase inhibitors treatment. Z.Mikrosk.-Anat.Forsch. (Leipzig) 104, 61-78 (1990).
30. RIBARD P., KAHN M.F.: Rheumatological side-effects of quinolones, pp. 175-191 in M.F. Kahn (Ed.): Bailliere's Clinical Rheumatology: Drug-Induced Rheumatic Diseases. Bailliere Tindall, London 1991.
31. SPURR A.R.: A low viscosity epoxy-resin embedding medium for electron microscopy. J.Ultrastruct.Res. 26, 3-43 (1969).
32. UMEZAWA N., ARAKANE K., RYU A., MASHIKO S., HINOBE M., NAGANO T.: Participation of reactive oxygen species in phototoxicity induced by quinolone antimicrobial agents. Arch.Biochem.Biophys. 342, 275-281 (1997).
33. WEIBEL E.R.: Principles and methods for morphometric study of the lung and other organs. Lab.Invest. 12, 131-155 (1963).